{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:39:08Z","timestamp":1793039948474,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Journal of Biological Sciences"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.sjbs.2021.06.043","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T03:38:18Z","timestamp":1623987498000},"page":"5833-5840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antitumor immunity enhancement through Newcastle viral oncolysate in mice model: A promising method to treat tumors"],"prefix":"10.1016","volume":"28","author":[{"given":"Amir Sasan","family":"Mozaffari Nejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Fotouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvaneh","family":"Mehrbod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Yousef","family":"Alikhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sjbs.2021.06.043_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104207","article-title":"Evaluation of the antitumor immune responses of probiotic Bifidobacterium bifidum in human papillomavirus-induced tumor model","volume":"145","author":"Abdolalipour","year":"2020","journal-title":"Microbial Pathog."},{"key":"10.1016\/j.sjbs.2021.06.043_b0010","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3390\/cancers3033279","article-title":"Assessment of the evolution of cancer treatment therapies","volume":"3","author":"Arruebo","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.sjbs.2021.06.043_b0015","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/BF03401771","article-title":"A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire","volume":"4","author":"Batliwalla","year":"1998","journal-title":"Mol Med"},{"key":"10.1016\/j.sjbs.2021.06.043_b0020","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4103\/0019-509X.73559","article-title":"Biological response modifiers: Current use and future prospects in cancer therapy","volume":"47","author":"Bisht","year":"2010","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.sjbs.2021.06.043_b0025","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26013","article-title":"Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+ T-cell responses to anticancer vaccines","volume":"2","author":"Bridle","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.sjbs.2021.06.043_b0030","series-title":"The oncolytic virus in cancer diagnosis and treatment","first-page":"10","author":"Cao","year":"2020"},{"key":"10.1016\/j.sjbs.2021.06.043_b0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.smim.2010.02.004","article-title":"Whole tumor antigen vaccines","author":"Chiang","year":"2010","journal-title":"Seminars in immunology (Elsevier)"},{"key":"10.1016\/j.sjbs.2021.06.043_b0040","first-page":"1","article-title":"Cytokines, interferons, and hematopoietic growth factors","author":"Ekmekcioglu","year":"2016","journal-title":"Holland-Frei Cancer Medicine"},{"key":"10.1016\/j.sjbs.2021.06.043_b0045","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1128\/JVI.00241-06","article-title":"Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death","volume":"80","author":"Elankumaran","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.sjbs.2021.06.043_b0050","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3389\/fphar.2018.01300","article-title":"Evolution of cancer pharmacological treatments at the turn of the third millennium","volume":"9","author":"Falzone","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.sjbs.2021.06.043_b0055","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/biology2030936","article-title":"Oncolytic Newcastle disease virus as cutting edge between tumor and host","volume":"2","author":"Fournier","year":"2013","journal-title":"Biology"},{"key":"10.1016\/j.sjbs.2021.06.043_b0060","first-page":"31","article-title":"Oncolytic virus therapy for cancer","volume":"2","author":"Goldufsky","year":"2013","journal-title":"Oncolytic Virother."},{"key":"10.1016\/j.sjbs.2021.06.043_b0065","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/107999099313532","article-title":"Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience","volume":"19","author":"Huang","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.sjbs.2021.06.043_b0070","first-page":"535","article-title":"Viral oncolysates in cancer treatment: immunological mechanisms of action","volume":"9","author":"Ioannides","year":"1989","journal-title":"Anticancer Res."},{"key":"10.1016\/j.sjbs.2021.06.043_b0075","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Critical Reviews\u2122 in Immunology"},{"key":"10.1016\/j.sjbs.2021.06.043_b0080","first-page":"509","article-title":"Effect of oral genistein administration in early and late phases of allergic encephalomyelitis","volume":"17","author":"Jahromi","year":"2014","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.sjbs.2021.06.043_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.coviro.2015.03.009","article-title":"Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints","volume":"13","author":"Jiang","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.sjbs.2021.06.043_b0090","first-page":"1","article-title":"Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment","volume":"17","author":"Keshavarz","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.sjbs.2021.06.043_b0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sjbs.2019.04.015","article-title":"Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis","volume":"27","author":"Keshavarz","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.sjbs.2021.06.043_b0100","first-page":"1","article-title":"Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy","volume":"26","author":"Keshavarz","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.sjbs.2021.06.043_b0105","doi-asserted-by":"crossref","first-page":"E313","DOI":"10.1002\/ijc.29202","article-title":"Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death","volume":"136","author":"Koks","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.sjbs.2021.06.043_b0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jgm.1005","article-title":"Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model","volume":"9","author":"Li","year":"2007","journal-title":"J. Gene Med."},{"key":"10.1016\/j.sjbs.2021.06.043_b0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virusres.2018.12.014","article-title":"Non-replicating Newcastle disease virus as an adjuvant for DNA vaccine enhances antitumor efficacy through the induction of TRAIL and granzyme B expression","volume":"261","author":"Mohebbi","year":"2019","journal-title":"Virus Res."},{"key":"10.1016\/j.sjbs.2021.06.043_b0120","first-page":"680","article-title":"Viral oncolysate in the management of malignant melanoma","volume":"40","author":"Murray","year":"1977","journal-title":"II. Clinical studies. Cancer"},{"key":"10.1016\/j.sjbs.2021.06.043_b0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/cgt.2010.65","article-title":"A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer","volume":"18","author":"Nakao","year":"2011","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.sjbs.2021.06.043_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104438","article-title":"Oncolytic effects of Hitchner B1 strain of newcastle disease virus against cervical cancer cell proliferation is mediated by the increased expression of cytochrome C, autophagy and apoptotic pathways","volume":"147","author":"Mozaffari Nejad","year":"2020","journal-title":"Microbial Pathog."},{"key":"10.1016\/j.sjbs.2021.06.043_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-021-01571-7","article-title":"A bibliometric review of oncolytic virus research as a novel approach for cancer therapy","volume":"18","author":"Mozaffari Nejad","year":"2021","journal-title":"Virol. J."},{"key":"10.1016\/j.sjbs.2021.06.043_b0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fimmu.2013.00129","article-title":"Regulation of adaptive immunity; the role of interleukin-10","volume":"4","author":"Ng","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.sjbs.2021.06.043_b0145","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00705-008-0057-2","article-title":"HN protein of Newcastle disease virus causes apoptosis in chicken embryo fibroblast cells","volume":"153","author":"Ravindra","year":"2008","journal-title":"Arch. Virol."},{"key":"10.1016\/j.sjbs.2021.06.043_b0150","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ijid.2020.12.015","article-title":"Prevalence, genotypes and phylogenetic analysis of human papillomaviruses (HPV) in northeast Iran","volume":"103","author":"Sabet","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.sjbs.2021.06.043_b0155","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer","volume":"71","author":"Sung","year":"2021","journal-title":"J. Clin."},{"key":"10.1016\/j.sjbs.2021.06.043_b0160","first-page":"178","article-title":"Oncolytic viruses in cancer therapy","volume":"254","author":"V\u00e4h\u00e4-Koskela","year":"2007","journal-title":"CancerLett."},{"key":"10.1016\/j.sjbs.2021.06.043_b0165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3389\/fimmu.2015.00663","article-title":"Exploiting the immunogenic potential of cancer cells for improved dendritic cell vaccines","volume":"6","author":"Vandenberk","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.sjbs.2021.06.043_b0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jso.2930130105","article-title":"A new approach in the immunotherapy of carcinoma of the colon and rectum","volume":"13","author":"Wallack","year":"1980","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.sjbs.2021.06.043_b0175","article-title":"Effect of radiotherapy on the survival of cervical cancer patients: an analysis based on SEER database","volume":"98","author":"Yang","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.sjbs.2021.06.043_b0180","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/mt.2008.286","article-title":"Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses","volume":"17","author":"Zamarin","year":"2009","journal-title":"Mol. Ther."}],"container-title":["Saudi Journal of Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X2100499X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X2100499X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:15:10Z","timestamp":1761153310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319562X2100499X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1319562X2100499X"],"URL":"https:\/\/doi.org\/10.1016\/j.sjbs.2021.06.043","relation":{},"ISSN":["1319-562X"],"issn-type":[{"value":"1319-562X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumor immunity enhancement through Newcastle viral oncolysate in mice model: A promising method to treat tumors","name":"articletitle","label":"Article Title"},{"value":"Saudi Journal of Biological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjbs.2021.06.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}